Finally, gene delivery experiments with a DNA plasmid encoding TRAIL that can trigger apoptosis in a wide variety of cancer cells, but not in normal cells, provided a proof of concept for a new promising strategy for cancer therapy combining gene therapy and APL-based chemotherapy. Here, TNFSF10 is linked to acute promyelocytic leukemia.